Eric Roos is Senior Vice President of Business Development & Corporate Strategy at BullFrog AI. He is responsible for scaling BullFrog’s end-to-end AI workflow for drug development through high-value corporate strategy, enterprise business development, strategic partnerships, and more. A seasoned biotech executive with more than 30 years of experience, Eric previously held roles like Chief Business Development Officer at Aspect Biosystems and Global Strategic Alliances Leader of Cell & Gene Therapy at Thermo Fisher Scientific. He earned his B.S. of Biochemistry at McGill University.